Lecture time

April 10, 2025 (Thursday) 16:20-18:20

Lecture location

Conference Room 809, Building 1, Jinfeng Laboratory

Lecture topic

Tumor heterogeneity analysis reveals the evolution and potential therapeutic targets of craniopharyngioma

Introduction to the speaker

Zhang Liguo,Researcher, PhD supervisor. He obtained his doctorate degree from Nanjing Agricultural University in 2012, and from 2013 to 2020, he worked in postdoctoral work at the Southwest Medical Center of the University of Texas and the Cincinnati Children's Hospital Medical Center. In 2021, he joined the National Key Laboratory of Biological Treatment at West China Hospital of Sichuan University. In 2022, it was selected into the National Overseas High-Level Talent Program Youth Project and Sichuan Province High-Level Talent Program. The related work is published as the first or corresponding author (including co-) in journals such as Cancer Cell, Nature Medicine, Developmental Cell, Oncogene, Molecular Biomedicine. He is currently working on two national natural surface projects, the National Overseas High-level Talent Youth Project, and the West China Hospital 135 Excellent Development Project.

Lecture summary

Professor Zhang Liguo's team mainly focuses on the cellular and molecular mechanisms of brain tumor recurrence and metastasis. Using single-cell analysis technology, neurobiology, stem cell biology and other technical means, mouse tumor models are used to combine clinical cases to study the cellular and molecular mechanisms of brain tumor formation such as medulloblastoma and glioblastoma, the origin of tumor cells and the development of new personalized treatment strategies.

Everyone is welcome to actively participate